Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Close this folderSection I - Setting the scene
Close this folderChapter I - Defining adherence
View the document1. What is adherence?
View the document2. The state-of-the-art measurement
View the document3. References
Open this folder and view contentsChapter II - The magnitude of the problem of poor adherence
Open this folder and view contentsChapter III - How does poor adherence affect policy-makers and health managers?
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Open this folder and view contentsSection III - Disease-Specific Reviews
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

3. References

1. Sabaté E. WHO Adherence Meeting Report. Geneva, World Health Organization, 2001.

2. Haynes RB. Determinants of compliance: The disease and the mechanics of treatment. Baltimore MD, Johns Hopkins University Press, 1979.

3. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. American Journal of Cardiology, 1993, 72: 68D-74D.

4. Dictionary of health services management, 2nd ed. Owing Mills, MD, National Health Publishing, 1982.

5. Timmreck TC, Randolph JF. Smoking cessation: clinical steps to improve compliance. Geriatrics, 1993, 48: 63-66.

6. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, 1999, 21: 1074-1090.

7. DiMatteo MR, DiNicola DD. Achieving patient compliance. New York, Pergamon, 1982.

8. Norell SE. Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Social Science & Medicine - Part E, Medical Psychology, 1981, 15: 57-61.

9. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York, Raven Press, 1991: 123-137.

10. Spector SL et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. Journal of Allergy & Clinical Immunology, 1986, 77: 65-70.

11. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 1986, 24: 67-74.

12. Freudenheim JL. A review of study designs and methods of dietary assessment in nutritional epidemiology of chronic disease. Journal of Nutrition, 1993, 123: 401-405.

13. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. American Review of Respiratory Disease, 1993, 147: 1311-1320.

14. Matsui D et al. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. Journal of Clinical Pharmacology, 1994, 34: 944-949.

15. Vitolins MZ et al. Measuring adherence to behavioral and medical interventions. Controlled Clinical Trials, 2000, 21: 188S-194S.

16. Nunnally JC, Bernstein IH. Psychometric theory, 3rd ed. New York, McGraw-Hill, 1994.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014